Lipson EJ - Search Results

1

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.

Topalian SL, Sznol M, McDermott DF, Kluger HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB, Powderly JD, Leming PD, Lipson EJ, Puzanov I, Smith DC, Taube JM, Wigginton JM, Kollia GD, Gupta A, Pardoll DM, Sosman JA, Hodi FS. Topalian SL, et al. Among authors: lipson ej. J Clin Oncol. 2014 Apr 1;32(10):1020-30. doi: 10.1200/JCO.2013.53.0105. Epub 2014 Mar 3. J Clin Oncol. 2014. PMID: 24590637 Free PMC article. Corrected and republished. Clinical Trial.

2

Art in oncology: how patients add life to their days.

Lipson EJ. Lipson EJ. J Clin Oncol. 2011 Apr 1;29(10):1392-3. doi: 10.1200/JCO.2010.33.9168. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300935 Free PMC article. No abstract available.

3

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.

Lipson EJ, Drake CG. Lipson EJ, et al. Clin Cancer Res. 2011 Nov 15;17(22):6958-62. doi: 10.1158/1078-0432.CCR-11-1595. Epub 2011 Sep 7. Clin Cancer Res. 2011. PMID: 21900389 Free PMC article. Review.

4

Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody.

Lipson EJ, Sharfman WH, Drake CG, Wollner I, Taube JM, Anders RA, Xu H, Yao S, Pons A, Chen L, Pardoll DM, Brahmer JR, Topalian SL. Lipson EJ, et al. Clin Cancer Res. 2013 Jan 15;19(2):462-8. doi: 10.1158/1078-0432.CCR-12-2625. Epub 2012 Nov 20. Clin Cancer Res. 2013. PMID: 23169436 Free PMC article. Clinical Trial.

5

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer.

Drake CG, Lipson EJ, Brahmer JR. Drake CG, et al. Among authors: lipson ej. Nat Rev Clin Oncol. 2014 Jan;11(1):24-37. doi: 10.1038/nrclinonc.2013.208. Epub 2013 Nov 19. Nat Rev Clin Oncol. 2014. PMID: 24247168 Free PMC article. Review.

6

PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival.

Lipson EJ, Vincent JG, Loyo M, Kagohara LT, Luber BS, Wang H, Xu H, Nayar SK, Wang TS, Sidransky D, Anders RA, Topalian SL, Taube JM. Lipson EJ, et al. Cancer Immunol Res. 2013 Jul;1(1):54-63. doi: 10.1158/2326-6066.CIR-13-0034. Cancer Immunol Res. 2013. PMID: 24416729 Free PMC article.

7

Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.

Lipson EJ, Bodell MA, Kraus ES, Sharfman WH. Lipson EJ, et al. J Clin Oncol. 2014 Jul 1;32(19):e69-71. doi: 10.1200/JCO.2013.49.2314. Epub 2014 Feb 3. J Clin Oncol. 2014. PMID: 24493726 Free PMC article. No abstract available.

8

Reply: Regulatory T cells-an important target for cancer immunotherapy.

Drake CG, Lipson EJ, Brahmer JR. Drake CG, et al. Among authors: lipson ej. Nat Rev Clin Oncol. 2014 Jun;11(6):307. doi: 10.1038/nrclinonc.2013.208-c2. Epub 2014 Apr 29. Nat Rev Clin Oncol. 2014. PMID: 24781414 Free PMC article. No abstract available.

9

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade.

Lipson EJ, Velculescu VE, Pritchard TS, Sausen M, Pardoll DM, Topalian SL, Diaz LA Jr. Lipson EJ, et al. J Immunother Cancer. 2014 Dec 16;2(1):42. doi: 10.1186/s40425-014-0042-0. eCollection 2014. J Immunother Cancer. 2014. PMID: 25516806 Free PMC article.

10

Nivolumab: targeting PD-1 to bolster antitumor immunity.

Brahmer JR, Hammers H, Lipson EJ. Brahmer JR, et al. Among authors: lipson ej. Future Oncol. 2015;11(9):1307-26. doi: 10.2217/fon.15.52. Epub 2015 Mar 23. Future Oncol. 2015. PMID: 25798726 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page